Mauro MJ, Hehlmann R, Williams LA, Goldberg SL, et al. Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITY. Leuk Lymphoma 2025 Jun 22:1-10. doi: 10.1080/10428194.2025.2495369.
PMID: 40545759